[Antineoplastic activity of Geranyl-hydroquinone]. 1968

R Lefevre, and R Fesneau, and J Laurain, and G Etienne

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006873 Hydroquinones Derivatives of hydroquinone (1,4-dihydrobenzene) made by reduction of BENZOQUINONES. Quinol,p-Dihydroxybenzenes,para-Dihydroxybenzenes,Quinols,p Dihydroxybenzenes,para Dihydroxybenzenes
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

R Lefevre, and R Fesneau, and J Laurain, and G Etienne
February 2002, European journal of medicinal chemistry,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
June 1980, Journal of medicinal chemistry,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
January 1966, Comptes rendus des seances de la Societe de biologie et de ses filiales,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
October 1967, Semaine therapeutique,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
January 1967, Therapie,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
September 1975, Journal of the National Cancer Institute,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
November 1969, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
August 1991, Journal of virological methods,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
January 1963, Farmakologiia i toksikologiia,
R Lefevre, and R Fesneau, and J Laurain, and G Etienne
August 2011, Phytotherapy research : PTR,
Copied contents to your clipboard!